This lecture will cover the basic information needed to properly perform and interpret baseline MRI for rectal cancer staging. It includes recommended techniques and parameters by the ESGAR 2012/2016 guidelines. It illustrates how to interpret T- and N- staging as well as proper assessment of the CRM and of EMVI. It discusses geographic differences in treatment around the world and also introduces staging of low rectal cancer involving the anal sphincter apparatus.
This abstract and the presentation materials are available to members only; a login is required.